multiple sclerosis

Introduction

Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). It primarily affects young adults and is characterized by episodes of neurological dysfunction and progressive disability. The disease is influenced by genetic and environmental factors and involves complex immune-mediated mechanisms.

Key Insights

Pathogenesis and Immune Mechanisms:
- MS is driven by an autoimmune response where T cells, B cells, and myeloid cells infiltrate the CNS, causing demyelination and neuro-axonal damage .
- Inflammation is a key driver of tissue injury at all stages of MS, with focal inflammatory infiltrates producing soluble factors that induce demyelination and neurodegeneration .
- Both cell-mediated and humorally mediated immune mechanisms contribute to the pathological injury in MS .
Clinical Course and Stages:
- MS typically begins with reversible episodes of neurological dysfunction (relapsing-remitting MS) and can progress to a stage of continuous and irreversible neurological decline (progressive MS) .
- The disease course is variable, with some patients experiencing a progressive disease from the onset .
Genetic and Environmental Factors:
- MS is influenced by a complex interplay of genetic predisposition and environmental factors, although specific environmental triggers remain unidentified .
Diagnosis and Biomarkers:
- Diagnosis relies on clinical symptoms, supported by laboratory and radiological investigations, including MRI and cerebrospinal fluid analysis .
- The McDonald diagnostic criteria are widely accepted for diagnosing MS.
Treatment and Management:
- Current treatments focus on reducing the frequency of relapses and managing symptoms, primarily using immunomodulatory therapies such as interferon β, glatiramer acetate, and other FDA-approved agents .
- There is a lack of effective treatments for progressive MS, highlighting the need for further research into disease mechanisms and therapeutic strategies .

Conclusion

Multiple sclerosis is a complex autoimmune disease characterized by inflammation, demyelination, and neurodegeneration. It involves a combination of genetic and environmental factors and progresses through distinct clinical stages. While current treatments can manage relapsing forms of MS, there is a significant need for effective therapies for progressive MS. Ongoing research aims to better understand the disease mechanisms, develop new treatments, and improve diagnostic criteria.

Multiple sclerosis

Summary

Introduction

Key Insights

Conclusion

Sources and full results

Multiple sclerosis

Multiple sclerosis (MS) is a chronic, immune-mediated disease characterized by demyelinating lesions in the central nervous system, leading to neurological dysfunction and significant social burden.

Multiple sclerosis.

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating, and neurodegenerative disease in young adults, influenced by genetic and environmental factors.

Multiple sclerosis: an immune or neurodegenerative disorder?

Multiple sclerosis is primarily a neurodegenerative disorder, with neurodegeneration being the major cause of irreversible neurological disability in MS patients.

Multiple Sclerosis: Pathogenesis and Treatment

Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease, with 8 FDA-approved agents for relapsing forms targeting different immune system parts, but no agents for primary progressive MS.

Multiple sclerosis

Multiple sclerosis is a chronic inflammatory brain and spinal cord disease characterized by progressive neurodegeneration and disability accumulation.

Multiple Sclerosis Pathology.

Inflammation drives tissue injury in multiple sclerosis, leading to demyelination and neurodegeneration, ultimately leading to "virtual hypoxia" in the central nervous system.

Multiple sclerosis.

Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system, with genetic factors and environmental factors playing significant roles in its development.

Progressive multiple sclerosis

Inflammation drives brain injury in progressive multiple sclerosis, and the discrepancy between inflammation-driven tissue injury and response to immunomodulatory therapies can be explained by different pathomechanisms in relapsing/remitting and progressive MS stages.

Multiple Sclerosis

MS is a chronic central nervous system inflammatory disease with no cure yet, but disease-modifying therapies show potential in preventing relapses, accumulation of lesions, and disability progression.

Multiple Sclerosis: Mechanisms and Immunotherapy

MS research focuses on understanding disease progression, developing treatments, and identifying potential preventative approaches.

Try another search